Transcriptome-Guided Advanced Cancer Hyperthermia Therapy
Molecular transcriptome-guided hyperthermia therapy heats the body to target cancer cells and slow their growth
Using high temperature and dialysis to restore and balance the body’s natural chemistry, the blood is then detoxified by a filter.

Hyperthermia Therapy
At Ayass BioScience, LLC and Verthermia®, we are dedicated to providing innovative and effective advanced cancer hyperthermia therapy through proprietary HEATT® (Hyperthermic Extracorporeal Applied Tumor Therapy) technology.
Therapy uses HEATT® for advanced tumors. WBHT, an innovative hyperthermia therapy for cancer, heats the body to target cancer cells and slow growth, effective in integrated oncology plans. HEATT® is effective for various types of cancer, including breast, colon, lung, and ovarian cancer.
HEATT® uses FDA-approved devices and follows strict safety protocols. HEATT® is a safe and non-invasive procedure with careful monitoring to ensure patient well-being.
The main difference between HEATT® and other hyperthermia treatments is that this system heat the blood directly and tightly control body temperature while normalizing fluids, electrolytes, and pH balance. HEATT® uses the patient’s own blood for whole-body hyperthermia to conduct heat rather than using typical conduction or convection methods.